| High-throughput mapping of B cell receptor sequences to antigen specificity I Setliff, AR Shiakolas, KA Pilewski, AA Murji, RE Mapengo, K Janowska, ... Cell 179 (7), 1636-1646. e15, 2019 | 290 | 2019 |
| Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions AR Shiakolas, KJ Kramer, D Wrapp, SI Richardson, A Schäfer, S Wall, ... Cell Reports Medicine 2 (6), 2021 | 72 | 2021 |
| Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking AR Shiakolas, KJ Kramer, NV Johnson, SC Wall, N Suryadevara, ... Nature biotechnology 40 (8), 1270-1275, 2022 | 44 | 2022 |
| Minimal antigenic evolution after a decade of norovirus GII. 4 Sydney_2012 circulation in humans GI Parra, K Tohma, LA Ford-Siltz, P Eguino, JA Kendra, KA Pilewski, ... Journal of Virology 97 (2), e01716-22, 2023 | 22 | 2023 |
| High-throughput B cell epitope determination by next-generation sequencing LM Walker, AR Shiakolas, R Venkat, ZA Liu, S Wall, N Raju, KA Pilewski, ... Frontiers in Immunology 13, 855772, 2022 | 20 | 2022 |
| Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor KA Pilewski, S Wall, SI Richardson, NP Manamela, K Clark, T Hermanus, ... Cell reports 42 (2), 2023 | 9 | 2023 |
| Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein LA Ford-Siltz, K Tohma, GS Alvarado, JA Kendra, KA Pilewski, ... Frontiers in Immunology 13, 1040836, 2022 | 8 | 2022 |
| Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions AR Shiakolas, KJ Kramer, D Wrapp, SI Richardson, A Schäfer, S Wall, ... bioRxiv, 2020.12. 20.414748, 2020 | 7 | 2020 |
| Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody NV Johnson, SC Wall, KJ Kramer, CM Holt, S Periasamy, SI Richardson, ... Structure 32 (11), 1893-1909. e11, 2024 | 5 | 2024 |
| Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking AR Shiakolas, N Johnson, KJ Kramer, N Suryadevara, D Wrapp, ... bioRxiv, 2021.06. 02.446813, 2021 | 5 | 2021 |
| Simultaneous immunization with multiple diverse immunogens alters development of antigen-specific antibody-mediated immunity KA Pilewski, KJ Kramer, IS Georgiev Vaccines 9 (9), 964, 2021 | 2 | 2021 |
| Antigenic Characterization of Novel Human Norovirus GII. 4 Variants San Francisco 2017 and Hong Kong 2019 K Tohma, M Landivar, LA Ford-Siltz, KA Pilewski, JA Kendra, S Niendorf, ... Emerging Infectious Diseases 30 (5), 1026, 2024 | 1 | 2024 |
| Analysis of Archival Sera From Norovirus-Infected Individuals Demonstrates That Cross-Blocking of Emerging Viruses Is Genotype-Specific KA Pilewski, LA Ford-Siltz, K Tohma, JA Kendra, M Landivar, GI Parra The Journal of Infectious Diseases, jiae085, 2024 | 1 | 2024 |
| Methods for identification of ligand-blocking antibodies and for determining antibody potency MF Setliff, IS Georgiev, A Shiakolas, K Pilewski, R Venkat US Patent App. 17/795,104, 2023 | | 2023 |
| Cross-reactive antibodies and uses thereof IS Georgiev, KA Pilewski US Patent App. 17/820,418, 2023 | | 2023 |
| Hiv/hcv cross-reactive antibodies and uses thereof K Pilewski, IS Georgiev US Patent App. 17/600,893, 2022 | | 2022 |
| Discovery and Characterization of Next-Generation Antibody and Vaccine Candidates KA Pilewski | | 2022 |
| Antibody cross-reactivity in chronic HIV/HCV co-infection K Pilewski, I Setliff, S Kalams, I Georgiev The Journal of Immunology 202 (1_Supplement), 72.7-72.7, 2019 | | 2019 |
| Therapeutic antibody discovery in lung tumors by B-cell receptor sequencing KJ Kramer, N Raju, A Greenplate, K Pilewski, P Massion, I Georgiev The Journal of Immunology 202 (1_Supplement), 138.7-138.7, 2019 | | 2019 |
